BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 2182892)

  • 1. Advantage of dose fractionation in monoclonal antibody-targeted radioimmunotherapy.
    Schlom J; Molinolo A; Simpson JF; Siler K; Roselli M; Hinkle G; Houchens DP; Colcher D
    J Natl Cancer Inst; 1990 May; 82(9):763-71. PubMed ID: 2182892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radioimmunotherapy of athymic mice bearing human colon carcinomas with monoclonal antibody B72.3: histological and autoradiographic study of effects on tumors and normal organs.
    Esteban JM; Schlom J; Mornex F; Colcher D
    Eur J Cancer Clin Oncol; 1987 Jun; 23(6):643-55. PubMed ID: 2820742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of multiple bolus and continuous injections of 131I-labeled CC49 for therapy in a colon cancer xenograft model.
    Buchsbaum DJ; Khazaeli MB; Mayo MS; Roberson PL
    Clin Cancer Res; 1999 Oct; 5(10 Suppl):3153s-3159s. PubMed ID: 10541357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic advantage of high-affinity anticarcinoma radioimmunoconjugates.
    Schlom J; Eggensperger D; Colcher D; Molinolo A; Houchens D; Miller LS; Hinkle G; Siler K
    Cancer Res; 1992 Mar; 52(5):1067-72. PubMed ID: 1310638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fractionated radioimmunotherapy of human colon carcinoma xenografts with 131I-labeled monoclonal antibody CC49.
    Buchsbaum D; Khazaeli MB; Liu T; Bright S; Richardson K; Jones M; Meredith R
    Cancer Res; 1995 Dec; 55(23 Suppl):5881s-5887s. PubMed ID: 7493364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic efficacy of a high-affinity anticarcinoembryonic antigen monoclonal antibody (COL-1).
    Siler K; Eggensperger D; Hand PH; Milenic DE; Miller LS; Houchens DP; Hinkle G; Schlom J
    Biotechnol Ther; 1993; 4(3-4):163-81. PubMed ID: 8292968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies concerning the effect of external irradiation on localization of radiolabeled monoclonal antibody B72.3 to human colon carcinoma xenografts.
    Shrivastav S; Schlom J; Raubitschek A; Molinolo A; Simpson J; Hand PH
    Int J Radiat Oncol Biol Phys; 1989 Mar; 16(3):721-9. PubMed ID: 2921170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization and biodistribution of recombinant and recombinant/chimeric constructs of monoclonal antibody B72.3.
    Colcher D; Milenic D; Roselli M; Raubitschek A; Yarranton G; King D; Adair J; Whittle N; Bodmer M; Schlom J
    Cancer Res; 1989 Apr; 49(7):1738-45. PubMed ID: 2924317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of dose and schedule on the therapeutic efficacy of 131I-labelled monoclonal antibody 139H2 in a human ovarian cancer xenograft model.
    Molthoff CF; Pinedo HM; Schlüper HM; Boven E
    Int J Cancer; 1992 Feb; 50(3):474-80. PubMed ID: 1735615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radioimmunolocalization of human carcinoma xenografts with B72.3 second generation monoclonal antibodies.
    Colcher D; Minelli MF; Roselli M; Muraro R; Simpson-Milenic D; Schlom J
    Cancer Res; 1988 Aug; 48(16):4597-603. PubMed ID: 3396011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I study of 90Y-labeled B72.3 intraperitoneal administration in patients with ovarian cancer: effect of dose and EDTA coadministration on pharmacokinetics and toxicity.
    Rosenblum MG; Verschraegen CF; Murray JL; Kudelka AP; Gano J; Cheung L; Kavanagh JJ
    Clin Cancer Res; 1999 May; 5(5):953-61. PubMed ID: 10353726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complementation of intracavitary and intravenous administration of a monoclonal antibody (B72.3) in patients with carcinoma.
    Colcher D; Esteban J; Carrasquillo JA; Sugarbaker P; Reynolds JC; Bryant G; Larson SM; Schlom J
    Cancer Res; 1987 Aug; 47(15):4218-24. PubMed ID: 3607761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolonged binding of a radiolabeled monoclonal antibody (B72.3) used for the in situ radioimmunodetection of human colon carcinoma xenografts.
    Colcher D; Keenan AM; Larson SM; Schlom J
    Cancer Res; 1984 Dec; 44(12 Pt 1):5744-51. PubMed ID: 6498836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal antibody-based therapy of a human tumor xenograft with a 177lutetium-labeled immunoconjugate.
    Schlom J; Siler K; Milenic DE; Eggensperger D; Colcher D; Miller LS; Houchens D; Cheng R; Kaplan D; Goeckeler W
    Cancer Res; 1991 Jun; 51(11):2889-96. PubMed ID: 1851665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted therapy of athymic mice bearing GW-39 human colonic cancer micrometastases with 131I-labeled monoclonal antibodies.
    Blumenthal RD; Sharkey RM; Haywood L; Natale AM; Wong GY; Siegel JA; Kennel SJ; Goldenberg DM
    Cancer Res; 1992 Nov; 52(21):6036-44. PubMed ID: 1394228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radioimmunotherapy of human colon cancer xenografts using a dimeric single-chain Fv antibody construct.
    Pavlinkova G; Booth BJ; Batra SK; Colcher D
    Clin Cancer Res; 1999 Sep; 5(9):2613-9. PubMed ID: 10499640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radioimmunodetection of human colon carcinoma xenografts in visceral organs of congenitally athymic mice.
    Lundy J; Mornex F; Keenan AM; Greiner JW; Colcher D
    Cancer; 1986 Feb; 57(3):503-9. PubMed ID: 3942982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ablation of human colon carcinoma in nude mice by 131I-labeled monoclonal anti-carcinoembryonic antigen antibody F(ab')2 fragments.
    Buchegger F; Pfister C; Fournier K; Prevel F; Schreyer M; Carrel S; Mach JP
    J Clin Invest; 1989 May; 83(5):1449-56. PubMed ID: 2708519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved treatment of medullary thyroid cancer in a nude mouse model by combined radioimmunochemotherapy: doxorubicin potentiates the therapeutic efficacy of radiolabeled antibodies in a radioresistant tumor type.
    Behr TM; Wulst E; Radetzky S; Blumenthal RD; Dunn RM; Gratz S; Rave-Fränk M; Schmidberger H; Raue F; Becker W
    Cancer Res; 1997 Dec; 57(23):5309-19. PubMed ID: 9393755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative and qualitative aspects of radiolocalization in colon cancer patients of intravenously administered MAb B72.3.
    Esteban JM; Colcher D; Sugarbaker P; Carrasquillo JA; Bryant G; Thor A; Reynolds JC; Larson SM; Schlom J
    Int J Cancer; 1987 Jan; 39(1):50-9. PubMed ID: 3793270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.